Key result
Prehypertension linked to ~44% higher CVD risk compared to optimal blood pressure.
Why the study?
Few systematic summaries exist on the relationship between prehypertension and the cardiovascular system, and consensus on optimal interventions is lacking.
Does prehypertension increase the risk of cardiovascular diseases compared to optimal blood pressure?
Does prehypertension increase the risk of cardiovascular diseases compared to optimal blood pressure?
Prehypertension is a major global health risk that adversely affects the cardiovascular system, highlighting the need for effective public health strategies to prevent its progression.
Prehypertension signals elevated CVD risk; confirms associations in reviews yet leaves intervention thresholds open pending trials.
In 1939, Robinson and Brucer first proposed the concept of prehypertension (PHTN), which was defined as a systolic blood pressure of 120-139 mmHg and/or diastolic blood pressure of 80-89 mmHg. PHTN is a major global health risk that adversely affects human health, especially the cardiovascular system. People with PHTN have a higher risk of developing cardiovascular diseases, including stroke, coronary heart disease, myocardial infarction and total cardiovascular events. However, there are few systematic summaries of the relationship between PHTN and the cardiovascular system. Furthermore, because the definition of 'normal BP' and the advantages of more intensive BP control remain unclear, there is no consensus on optimal interventions. In an attempt to provide information for clinicians or professionals who are interested in reducing the risk associated with PHTN, we review the existing studies to provide references for them with the effects of PHTN on the cardiovascular system and the potential pathogenic mechanisms of PHTN, including inflammatory responses, insulin resistance, endothelial dysfunction, sympathovagal imbalance, activation of the renin-angiotensin system and others. PHTN is highly prevalent and has adverse effects on health. An effective public health strategy is important to prevent the progression of PHTN. We envisage that this information will increase the public attention of PHTN and help to provide more strategies to reduce the risk of cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2021) conducted a review in Prehypertension. Prehypertension vs. Optimal blood pressure (≤120/80 mmHg) was evaluated on Cardiovascular diseases and pathogenic mechanisms. Prehypertension increases the risk of cardiovascular disease by 1.44 times compared to optimal blood pressure and is associated with pathogenic mechanisms including inflammation and endothelial dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: